These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25407935)

  • 21. Sensitive HPLC method for quantitation of paclitaxel (Genexol in biological samples with application to preclinical pharmacokinetics and biodistribution.
    Kim SC; Yu J; Lee JW; Park ES; Chi SC
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):170-6. PubMed ID: 16085137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
    Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
    Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I and pharmacokinetic study of AI-850, a novel microparticle hydrophobic drug delivery system for paclitaxel.
    Mita AC; Olszanski AJ; Walovitch RC; Perez RP; MacKay K; Tuck DP; Simmons C; Hammond S; Mita MM; Beeram M; Stone AJ; Rowinsky EK; Lewis LD
    Clin Cancer Res; 2007 Jun; 13(11):3293-301. PubMed ID: 17545535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taxoids in combination with anthracyclines and other agents: pharmacokinetic considerations.
    D'Incalci M; Schüller J; Colombo T; Zucchetti M; Riva A
    Semin Oncol; 1998 Dec; 25(6 Suppl 13):16-20. PubMed ID: 9865687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nano-sized cationic polymeric magnetic liposomes significantly improves drug delivery to the brain in rats.
    Zhao M; Chang J; Fu X; Liang C; Liang S; Yan R; Li A
    J Drug Target; 2012 Jun; 20(5):416-21. PubMed ID: 22519867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel poliglumex (XYOTAX, CT-2103): a macromolecular taxane.
    Singer JW
    J Control Release; 2005 Dec; 109(1-3):120-6. PubMed ID: 16297482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different tissue distribution of paclitaxel with intravenous and intraperitoneal administration.
    Soma D; Kitayama J; Ishigami H; Kaisaki S; Nagawa H
    J Surg Res; 2009 Jul; 155(1):142-6. PubMed ID: 19328496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles.
    Calleja P; Espuelas S; Vauthier C; Ponchel G; Irache JM
    J Pharm Sci; 2015 Sep; 104(9):2877-86. PubMed ID: 25600579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
    de Bree E; Rosing H; Filis D; Romanos J; Melisssourgaki M; Daskalakis M; Pilatou M; Sanidas E; Taflampas P; Kalbakis K; Beijnen JH; Tsiftsis DD
    Ann Surg Oncol; 2008 Apr; 15(4):1183-92. PubMed ID: 18239973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer.
    Yamamoto R; Kaneuchi M; Nishiya M; Todo Y; Takeda M; Okamoto K; Negishi H; Sakuragi N; Fujimoto S; Hirano T
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):137-42. PubMed ID: 12172979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of advanced gastric cancer treated with weekly paclitaxel with measurement of paclitaxel concentrations in blood and ascites].
    Kojima T; Matsui T; Uemura T; Fujimitsu Y; Kato J; Kojima H
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1529-31. PubMed ID: 14584291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity.
    Wang F; Shen Y; Xu X; Lv L; Li Y; Liu J; Li M; Guo A; Guo S; Jin F
    Int J Pharm; 2013 Nov; 456(1):101-12. PubMed ID: 23968782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility study and pharmacokinetics of low-dose paclitaxel in cancer patients with severe hepatic dysfunction.
    Briasoulis E; Karavasilis V; Tzamakou E; Piperidou C; Soulti K; Pavlidis N
    Anticancer Drugs; 2006 Nov; 17(10):1219-22. PubMed ID: 17075322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
    Bradley MO; Webb NL; Anthony FH; Devanesan P; Witman PA; Hemamalini S; Chander MC; Baker SD; He L; Horwitz SB; Swindell CS
    Clin Cancer Res; 2001 Oct; 7(10):3229-38. PubMed ID: 11595719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonvascular drug-eluting stent coated with sodium caprate-incorporated polyurethane for the efficient penetration of paclitaxel into tumor tissue.
    Jeong D; Lee DH; Lee DK; Na K
    J Biomater Appl; 2015 Mar; 29(8):1133-44. PubMed ID: 25252589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel pharmacokinetics and response to chemotherapy in patients with advanced cancer treated with a weekly regimen.
    Mielke S; Sparreboom A; Behringer D; Mross K
    Anticancer Res; 2005; 25(6C):4423-7. PubMed ID: 16334120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver.
    Camacho LH; Kurzrock R; Cheung A; Barber DF; Gupta S; Madoff DC; Wallace MJ; Kim EE; Curley SA; Hortobagyi GN; Mavligit G
    Cancer; 2007 Jun; 109(11):2190-6. PubMed ID: 17464952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels following application of paclitaxel-coated balloon catheters in patients with stenotic or occluded femoropopliteal arteries.
    Freyhardt P; Zeller T; Kröncke TJ; Schwarzwaelder U; Schreiter NF; Stiepani H; Sixt S; Rastan A; Werk M
    Rofo; 2011 May; 183(5):448-55. PubMed ID: 21274828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and neutrophil toxicity of paclitaxel orally administered in mice with recombinant interleukin-2.
    Jamois C; Comets E; Mentré F; Marion S; Farinotti R; Bonhomme-Faivre L
    Cancer Chemother Pharmacol; 2005 Jan; 55(1):61-71. PubMed ID: 15378273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles.
    Bao QY; Zhang N; Geng DD; Xue JW; Merritt M; Zhang C; Ding Y
    Int J Pharm; 2014 Dec; 477(1-2):408-15. PubMed ID: 25455782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.